Australian and New Zealand Intensive Care Society’s Clinical Trials Group (CTG) Chair Award presented in recognition of outstanding contribution to the development of the CTG. The award was presented in the CTG’s 20th anniversary year. Prof Cooper’s service to the CTG included more than 10 years on the Executive, and three as Chair (2007-2009) nurturing the development of this group to its current position. The CTG is a bi-national network of collaborating clinicians that has achieved international recognition as one of the two most successful and influential independent clinical research consortia in critical care in the world and continually generates new evidence to improve outcomes for critically ill patients. This group has an outstanding reputation for publishing pivotal clinical trials in critical care medicine and is responsible for a quarter of all original articles from Australia published in NEJM (Impact factor 55.873) in the past decade. The CTG has completed the three largest ICU trials in the world to date, for a total of >20,000 randomised patients. The only equivalent ICU network in the USA, is the ARDS Trials Network which has randomised <4,000 patients. The efficiency of randomisation of the Australian structure adjusted for population is currently approximately 800 patients randomised / million people compared to approximately 12 patients / million people in the USA (a >60 fold greater efficiency).
Degree of recognition
Australia and New Zealand Intensive Care Society (ANZICS)